Table 2 Demographic and preoperative data of the patients

Male/female

32/16

64.7/33%

Age (years)

25-73

55.2 + 12.97

Pericardial effusion-free interval (months)

1-48

13.47 ± 10.34

Hb (g/dL)

9.6-16

11.65 ± 1.34

EF (%)

40-66

54.37 ± 5.89

Central venous pressure (cm H₂0)

15-26

17 ± 7.6

n

%

Cancer type (n)

Breast

8

16.6

Hematologic

7

14.5

Lung

21

43.7

Other

12

25

Appearance of effusion (n)

Hemorrhagic

18

37.5

Serous

29

60.4

Purulent

1

2.1

Pericardial effusion type (n)

Malignant

26

54.2

Benign

22

45.8

Accompanying pleural effusion (n)

23

47.9

Malignant

12

52.2

Benign

11

47.8

Radiotherapy prior to or during tamponade

13

27

Chemotherapy prior to or during tamponade

48

100

Distant metastasis

14

35.9

Overt tamponade

48

100

Prior pericardiocentesis

19

40